Koji Matsuo Selected Research

Female Genital Diseases

1/2022	Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasia.
1/2021	Risk of Upper-body Adverse Events in Robot-assisted Total Laparoscopic Hysterectomy for Benign Gynecologic Disease.
11/2020	The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
9/2020	Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Matsuo Research Topics

Disease

107	Neoplasms (Cancer) 09/2022 - 10/2009
53	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 02/2010
53	Endometrial Neoplasms (Endometrial Cancer) 08/2022 - 01/2012
39	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2010
21	Ovarian Epithelial Carcinoma 02/2021 - 06/2010
18	Neoplasm Metastasis (Metastasis) 03/2022 - 10/2011
17	Carcinoma (Carcinomatosis) 11/2021 - 02/2010
10	Obesity 03/2022 - 07/2016
10	Carcinosarcoma 01/2021 - 08/2010
9	Placenta Accreta 01/2022 - 01/2020
8	Adenocarcinoma 01/2022 - 10/2012
8	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2009
7	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 10/2007
6	Hemorrhage 03/2022 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 09/2015
6	Endometrial Hyperplasia 01/2022 - 12/2014
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2012
5	Rupture 01/2021 - 01/2019
5	Endometriosis 04/2019 - 10/2009
5	Diabetes Mellitus 07/2016 - 06/2012
4	Venous Thromboembolism 03/2022 - 09/2015
4	Female Genital Diseases 01/2022 - 09/2020
4	Uterine Neoplasms (Uterine Cancer) 01/2021 - 05/2014
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2017
4	Lymphatic Metastasis 01/2020 - 02/2012
3	Vulvar Neoplasms (Vulvar Cancer) 01/2022 - 01/2018
3	Adenosquamous Carcinoma 01/2022 - 10/2012
3	Hyperplasia 01/2020 - 01/2019
3	Hypertension (High Blood Pressure) 01/2020 - 01/2016
3	Chronic Renal Insufficiency 01/2018 - 05/2015
3	Thrombocytosis (Thrombocythemia) 11/2017 - 02/2012
3	Disease Progression 05/2016 - 08/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2009 - 07/2003
2	Ischemia 08/2022 - 12/2021
2	Ovarian Cysts (Ovarian Cyst) 08/2022 - 04/2019
2	Inclusion Body Myositis 01/2022 - 01/2017
2	Inflammation (Inflammations) 12/2021 - 01/2018
2	Uremia 01/2021 - 05/2015
2	Leiomyosarcoma 01/2021 - 01/2021
2	Morbid Obesity 01/2021 - 02/2016

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
14	PlatinumIBA 09/2021 - 12/2009
11	Biological ProductsIBA 11/2021 - 12/2009
11	Proteins (Proteins, Gene)FDA Link 08/2020 - 04/2013
6	AntigensIBA 01/2021 - 12/2015
6	Small Interfering RNA (siRNA)IBA 01/2020 - 05/2010
6	Indicators and Reagents (Reagents)IBA 12/2015 - 12/2011
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2022 - 02/2016
5	CytokinesIBA 12/2021 - 05/2010
5	taxaneIBA 01/2019 - 12/2009
4	RNA (Ribonucleic Acid)IBA 12/2021 - 11/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 02/2012
4	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 04/2013
4	Capsules (Microcapsules)IBA 01/2021 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2010
4	Hemoglobins (Hemoglobin)IBA 10/2004 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 10/2011
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2014
3	GlycopeptidesIBA 08/2020 - 04/2019
3	Progestins (Progestagens)IBA 01/2020 - 01/2019
3	Glycoproteins (Glycoprotein)IBA 04/2019 - 12/2015
3	liposomal doxorubicin (Doxil)FDA Link 01/2019 - 11/2010
3	Estrogen ReceptorsIBA 03/2016 - 10/2011
3	1,2-oleoylphosphatidylcholine (DOPC)IBA 02/2015 - 05/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 12/2021 - 04/2010
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 12/2020
2	Immunoconjugates (Immunoconjugate)IBA 09/2021 - 01/2021
2	ElementsIBA 01/2021 - 09/2018
2	Monoclonal AntibodiesIBA 01/2021 - 05/2014
2	AntibodiesIBA 01/2021 - 09/2015
2	Enoxaparin (Lovenox)FDA LinkGeneric 11/2020 - 01/2020

Therapy/Procedure

96	Hysterectomy 09/2022 - 02/2010
40	Therapeutics 09/2022 - 05/2003
33	Drug Therapy (Chemotherapy) 03/2022 - 12/2009
24	Radiotherapy 03/2022 - 11/2011
18	Lymph Node Excision (Lymph Node Dissection) 08/2022 - 10/2012
12	Neoadjuvant Therapy 01/2022 - 02/2010
11	Ovariectomy (Oophorectomy) 08/2022 - 01/2016
8	Adjuvant Radiotherapy 03/2022 - 11/2011
8	Cytoreduction Surgical Procedures 01/2021 - 10/2009
7	Minimally Invasive Surgical Procedures 10/2021 - 01/2019
7	Trachelectomy 01/2021 - 11/2018
5	Pelvic Exenteration 01/2021 - 01/2019
4	Conservative Treatment 01/2022 - 01/2020
4	Chemoradiotherapy 01/2022 - 12/2020
4	Laparotomy 01/2021 - 10/2009
4	Operative Surgical Procedures 01/2020 - 05/2019
3	Brachytherapy 03/2022 - 01/2017
3	Salpingectomy 01/2022 - 11/2020
3	Adjuvant Chemotherapy 01/2021 - 12/2011
2	Cystectomy 08/2022 - 06/2011
2	Laparoscopic Cholecystectomy 01/2022 - 10/2021
2	Operative Time 01/2022 - 08/2017
2	Tubal Sterilization (Tubal Ligation) 01/2022 - 10/2021
2	Vulvectomy 01/2022 - 01/2021
2	Blood Transfusion (Blood Transfusions) 12/2021 - 10/2021
2	Gynecologic Surgical Procedures (Gynecologic Surgery) 10/2021 - 11/2020
2	Urinary Diversion (Ileal Conduit) 01/2021 - 01/2019
2	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 01/2021